Autopsy report · NCT02618499

Delayed Cord Clamping and Use of Oxytocin

“Futility suggested by DSMC”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 6 months before it stopped.
• 180 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Fundacion para la Salud Materno Infantil

Sponsor type

University, hospital or other

Conditions

Placental Transfusion

Interventions

Timing of administration of post partum Oxytocin

Participants

180

Sites

1

Countries

Argentina

Trials that died the same way

• Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
  “DSMB advise due to high probability of futility” (72% match in meaning)
• Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)
  “Recommendation by the DSMB that the study be stopped for futility” (69% match in meaning)
• Ketamine in Refractory Convulsive Status Epilepticus
  “Futility” (67% match in meaning)
• Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
  “Assessment for futility” (63% match in meaning)
• Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
  “Interim futility analysis” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.